Skip to content

LENSAR, Inc. LNSR Investing Cash Flow

Investing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.04B-250%
Staar Surgical logo
Staar SurgicalSTAA
$2.15M-93.9%
Bausch + Lomb logo
Bausch + LombBLCO
-$130M-12.1%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$645K-252%
Schering-Plough logo
Schering-PloughSGP
-$1.67M-916%
IAR
Integra LifeSciencesIART
-$14.85M+58.7%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s investing cash flow?
LENSAR, Inc. (LNSR) reported investing cash flow of $4M in Q1 2026.
How has LENSAR, Inc.'s investing cash flow changed year-over-year?
LENSAR, Inc.'s investing cash flow increased by 653.3% year-over-year, from $531K to $4M.
What is the long-term trend for LENSAR, Inc.'s investing cash flow?
Over 3 years (2021 to 2025), LENSAR, Inc.'s investing cash flow has grown at a 53.6% compound annual growth rate (CAGR), from -$354K to $1.28M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.